                         SEQUENCE LISTING

<110>  Vanderbilt University
 
<120>  ANTIBODY COCKTAIL FOR TREATMENT OF EBOLAVIRUS INFECTIONS

<130>  VBLT.P0316WO

<150>  US 63/177,528
<151>  2021-04-21

<160>  31    

<170>  PatentIn version 3.5

<210>  1
<211>  408
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  1
gaggtgcagt tggtggagtc tgggggaggc ctcgtaaagc cgggggggtc ccttagactc       60

tcctgtacag gctctggagg cactggattc actttcaagt atgccgggat gagctgggtc      120

cgccaggctc cagggaaggg gccggagtgg attggccgta ttaaaagcag gattgatggt      180

gggacaacag actacgctgc acccgtgaaa gacagattca ttgtctcaag agatgattca      240

agaaatacac tctatctgca aatgaacagc ctgaagaccg aggacacagc cgtctattat      300

tgtgccacag gatcgggaaa ggggccctct gcgtcgttcg gggagtcata ctactactac      360

gacttcatta acgtctgggg caaagggacc acggtcaccg tctcctca                   408


<210>  2
<211>  324
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  2
gaaagtgtgt tgacgcagtc tccaggcacc ctgtctttgt ctccagggga aagagccacc       60

ctctcgtgca gggccagtca gagtattagc aggaagtact tagcctggta ccagcagaaa      120

cctggccagg ctcccaggct cctcatctat ggttcatcca gcagggccac tggcatccca      180

gacagattca gtggcagtgg gtctgggaca gacttcactc tcaccatcag cagactggag      240

cctgaagatt ttgcagtgta ttactgtcat cagtatgaaa gctcaccttg gacgttcggc      300

caagggacta aggtggaaat caaa                                             324


<210>  3
<211>  136
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  3

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Lys Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Thr Gly Ser Gly Gly Thr Gly Phe Thr Phe 
            20                  25                  30          


Lys Tyr Ala Gly Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Pro 
        35                  40                  45              


Glu Trp Ile Gly Arg Ile Lys Ser Arg Ile Asp Gly Gly Thr Thr Asp 
    50                  55                  60                  


Tyr Ala Ala Pro Val Lys Asp Arg Phe Ile Val Ser Arg Asp Asp Ser 
65                  70                  75                  80  


Arg Asn Thr Leu Tyr Leu Gln Met Asn Ser Leu Lys Thr Glu Asp Thr 
                85                  90                  95      


Ala Val Tyr Tyr Cys Ala Thr Gly Ser Gly Lys Gly Pro Ser Ala Ser 
            100                 105                 110         


Phe Gly Glu Ser Tyr Tyr Tyr Tyr Asp Phe Ile Asn Val Trp Gly Lys 
        115                 120                 125             


Gly Thr Thr Val Thr Val Ser Ser 
    130                 135     


<210>  4
<211>  108
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  4

Glu Ser Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Ile Ser Arg Lys 
            20                  25                  30          


Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Ile Tyr Gly Ser Ser Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu 
65                  70                  75                  80  


Pro Glu Asp Phe Ala Val Tyr Tyr Cys His Gln Tyr Glu Ser Ser Pro 
                85                  90                  95      


Trp Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105             


<210>  5
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  5

Gly Phe Thr Phe Lys Tyr Ala Gly 
1               5               


<210>  6
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  6

Ile Lys Ser Arg Ile Asp Gly Gly Thr Thr 
1               5                   10  


<210>  7
<211>  24
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  7

Ala Thr Gly Ser Gly Lys Gly Pro Ser Ala Ser Phe Gly Glu Ser Tyr 
1               5                   10                  15      


Tyr Tyr Tyr Asp Phe Ile Asn Val 
            20                  


<210>  8
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  8

Gln Ser Ile Ser Arg Lys Tyr 
1               5           


<210>  9
<211>  3
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  9

Gly Ser Ser 
1           


<210>  10
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  10

His Gln Tyr Glu Ser Ser Pro Trp Thr 
1               5                   


<210>  11
<211>  366
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  11
caggtgcagc tgcacgagtc gggcccagga ctggtgaagc cttcacagac cctgtccctc       60

acctgcactg tctctggtgg gtccatcaac agtgctggtt actactggac ctggatccgc      120

cagcacccgg ggaagggcct ggagtggatt gggtacatcg attatactgg gaggacctac      180

tacaacccgt cccttgagag ccgagtgatc atttcaatag acacgtctaa gaaccacttc      240

tccctgagac tgacctctgt gtctgccgcg gacacggccg tgtattactg tgcgcgagaa      300

tcgtcgtggg tatccgagtt agggcgtgac aactggggcc agggaaccct ggtcaccgtc      360

tcttca                                                                 366


<210>  12
<211>  321
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  12
gaaatagtga tgacgcagtc tccagccacc ctgcctgtgt ctccagggga aggagccacc       60

ctctcctgca gggccagtca gagtgttttc accaacttag cctggtacca gcaaaaacct      120

ggccaggctc ccaggctcct catctatgat gcatccacca gggccactgg tatcccagcc      180

aggttcagtg gcagtgggtc tgggacagag ttcactctca ccatcagcag cctgcagtct      240

gaagactttg cagtttatta ttgtcagcag tataataact ggcctcggac gtacggccaa      300

gggaccaggg tggaagtcaa a                                                321


<210>  13
<211>  122
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  13

Gln Val Gln Leu His Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Gln 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Ile Asn Ser Ala 
            20                  25                  30          


Gly Tyr Tyr Trp Thr Trp Ile Arg Gln His Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Tyr Ile Asp Tyr Thr Gly Arg Thr Tyr Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Glu Ser Arg Val Ile Ile Ser Ile Asp Thr Ser Lys Asn His Phe 
65                  70                  75                  80  


Ser Leu Arg Leu Thr Ser Val Ser Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Glu Ser Ser Trp Val Ser Glu Leu Gly Arg Asp Asn Trp 
            100                 105                 110         


Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120         


<210>  14
<211>  107
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  14

Glu Ile Val Met Thr Gln Ser Pro Ala Thr Leu Pro Val Ser Pro Gly 
1               5                   10                  15      


Glu Gly Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Phe Thr Asn 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Ser Thr Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Ser 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Asn Asn Trp Pro Arg 
                85                  90                  95      


Thr Tyr Gly Gln Gly Thr Arg Val Glu Val Lys 
            100                 105         


<210>  15
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  15

Gly Gly Ser Ile Asn Ser Ala Gly Tyr Tyr 
1               5                   10  


<210>  16
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  16

Ile Asp Tyr Thr Gly Arg Thr 
1               5           


<210>  17
<211>  14
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  17

Ala Arg Glu Ser Ser Trp Val Ser Glu Leu Gly Arg Asp Asn 
1               5                   10                  


<210>  18
<211>  6
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  18

Gln Ser Val Phe Thr Asn 
1               5       


<210>  19
<211>  3
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  19

Asp Ala Ser 
1           


<210>  20
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic antibody

<400>  20

Gln Gln Tyr Asn Asn Trp Pro Arg Thr 
1               5                   


<210>  21
<211>  21
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic primer

<400>  21
ccgtcaatca aggagcgcct c                                                 21


<210>  22
<211>  20
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic primer

<400>  22
cgcaacctcc acagtcgcct                                                   20


<210>  23
<211>  21
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic primer

<400>  23
catccaatca aagacattgc g                                                 21


<210>  24
<211>  40
<212>  PRT
<213>  Ebola virus

<400>  24

Glu Trp Ala Glu Asn Cys Tyr Asn Leu Glu Ile Lys Lys Pro Asp Gly 
1               5                   10                  15      


Ser Glu Cys Leu Pro Ala Ala Pro Asp Gly Ile Arg Gly Phe Pro Arg 
            20                  25                  30          


Cys Arg Tyr Val His Lys Val Ser 
        35                  40  


<210>  25
<211>  60
<212>  PRT
<213>  Ebola virus

<400>  25

Asn Ala Gln Pro Lys Cys Asn Pro Asn Leu His Tyr Trp Thr Thr Gln 
1               5                   10                  15      


Asp Glu Gly Ala Ala Ile Gly Leu Ala Trp Ile Pro Tyr Phe Gly Pro 
            20                  25                  30          


Ala Ala Glu Gly Ile Tyr Ile Glu Gly Leu Met His Asn Gln Asp Gly 
        35                  40                  45              


Leu Ile Cys Gly Leu Arg Gln Leu Ala Asn Glu Thr 
    50                  55                  60  


<210>  26
<211>  63
<212>  PRT
<213>  Ebola virus

<400>  26

Asn Gly Val Ala Thr Asp Val Pro Ser Ala Glu Trp Ala Glu Asn Cys 
1               5                   10                  15      


Tyr Asn Leu Glu Ile Lys Lys Pro Asp Gly Ser Glu Cys Leu Pro Ala 
            20                  25                  30          


Ala Pro Asp Gly Ile Arg Gly Phe Pro Arg Cys Arg Tyr Val His Lys 
        35                  40                  45              


Val Ser Gln Leu Glu Ser Arg Phe Thr Pro Gln Phe Leu Leu Gln 
    50                  55                  60              


<210>  27
<211>  60
<212>  PRT
<213>  Ebola virus

<400>  27

Asn Ala Gln Pro Lys Cys Asn Pro Asn Leu His Tyr Trp Thr Thr Gln 
1               5                   10                  15      


Asp Glu Gly Ala Ala Ile Gly Leu Ala Trp Ile Pro Tyr Phe Gly Pro 
            20                  25                  30          


Ala Ala Glu Gly Ile Tyr Ile Glu Gly Leu Met His Asn Gln Asp Gly 
        35                  40                  45              


Leu Ile Cys Gly Leu Arg Gln Leu Ala Asn Glu Thr 
    50                  55                  60  


<210>  28
<211>  60
<212>  PRT
<213>  Ebola virus

<400>  28

Leu Arg Ser Val Gly Leu Asn Leu Glu Gly Asn Gly Val Ala Thr Asp 
1               5                   10                  15      


Val Pro Ser Ala Thr Lys Arg Trp Gly Phe Arg Ser Gly Val Pro Pro 
            20                  25                  30          


Lys Val Val Asn Tyr Glu Ala Gly Glu Trp Ala Glu Asn Cys Tyr Asn 
        35                  40                  45              


Leu Glu Pro Arg Cys Arg Tyr Val His Lys Val Ser 
    50                  55                  60  


<210>  29
<211>  60
<212>  PRT
<213>  Ebola virus

<400>  29

Asn Ala Gln Pro Lys Cys Asn Pro Asn Leu His Tyr Trp Thr Thr Gln 
1               5                   10                  15      


Asp Glu Gly Ala Ala Ile Gly Leu Ala Trp Ile Pro Tyr Phe Gly Pro 
            20                  25                  30          


Ala Ala Glu Gly Ile Tyr Ile Glu Gly Leu Met His Asn Gln Asp Gly 
        35                  40                  45              


Leu Ile Cys Gly Leu Arg Gln Leu Ala Asn Glu Thr 
    50                  55                  60  


<210>  30
<211>  4
<212>  PRT
<213>  Ebola virus

<400>  30

Glu Gln His Asn 
1               


<210>  31
<211>  4
<212>  PRT
<213>  Ebola virus

<400>  31

Asp Arg Pro His 
1               


